Because of these issues, recent studies have investigated serum markers such as HE4 (6), TFPI2 (9), circulating tumor DNA (54, 55), DNA methylation (56), and circulating miRNA (11) as complementary markers to CA125. This evidence concerns the gene TFPI2 and neoplasm.